AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
2.31 USD
-1.7%
Market Closed
Updated:
May 11, 2024
AC Immune SA
Selling, General & Administrative
|
AC Immune SA
Selling, General & Administrative Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Selling, General & Administrative
-CHf10.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Selling, General & Administrative
-$105.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Selling, General & Administrative
-$206.4m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Selling, General & Administrative
-CHf33.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Selling, General & Administrative
-CHf504m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Selling, General & Administrative
-CHf27.5m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Selling, General & Administrative?
Selling, General & Administrative
-10.6m
CHF
-10.6m
CHF
Based on the financial report for Dec 31, 2023, AC Immune SA's Selling, General & Administrative amounts to -10.6m CHF.
What is AC Immune SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-7%
-7%
Over the last year, the Selling, General & Administrative growth was -10%. The average annual Selling, General & Administrative growth rates for AC Immune SA have been 2% over the past three years , -7% over the past five years .
You don't have any saved screeners yet
